Brief: Clinuvel Pharmaceuticals Posts FY Pretax Profit AUD 50.7 Mln
29/08/2024 24:29
Aug 29 (Reuters) - Clinuvel Pharmaceuticals Ltd FY net income AUD 35.6 million. * FY pretax profit AUD 50.7 million * FY adjusted net income AUD 42.1 million * FY revenue AUD 88.2 million
Recent news on Clinuvel Pharmaceuticals
See all newsBrief: Clinuvel Pharmaceuticals Announces Strategic Reorganisation To Refocus On U.S. Markets
Brief: Clinuvel Pharmaceuticals Ltd's ADS To Commence Trading On Nasdaq
Brief: Clinuvel Pharmaceuticals Says Scenesse Approved For EPP In Canada
Australia's Clinuvel Pharmaceuticals rises on Canada nod for phototoxicity prevention drug
Brief: Clinuvel Pharmaceuticals Updates On Level II ADR Upgrade, Nasdaq Uplist